Senior insider sale
CEO and President at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$78.8K
22.41K shares
What this filing means
KHAN NAJAT plans to sell 22.41K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $78.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001628280-26-060859
DirectorOfficer· CEO and President
Since Feb 2026
22.41K
Shares to sell
$78.8K
Approx. market value
24.90K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Equity Compensation
Equity Compensation
8/15/2026
18.42KEquity Compensation
Equity Compensation
8/15/2026
6.48KTotal acquired24.90K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2026 | Equity Compensation Equity Compensation | 18.42K | — |
8/15/2026 | Equity Compensation Equity Compensation | 6.48K | — |
| Total | 24.90K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
22.41K
Market value
$78.8K
9/8/2026
Total
Units
22.41K
Value
$78.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/8/2026 | 22.41K | $78.8K | NASDAQ | Planned |
| Total | 22.41K | $78.8K | ||